[artículo] 
inThe Journal of Clinical Psychiatry > Año 2011 - Vol.72 - No. 4 (Abril) . - pp. 522-528

Título :	Prophylactic treatment with escitalopram of pegylated interferon alfa 2a induced depression in hepatitis C. : a 12 week, randomized, double-blind, placebo controlled trial
Tipo de documento:	texto impreso
Autores:	Crisanto Díez Quevedo, Autor ; Helena Masnou, Autor ; Ramon Planas, Autor
Fecha de publicación:	2022
Artículo en la página:	pp. 522-528
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Antivirales, Citalopram, Trastorno depresivo mayor, Hepatitis C., Interferón alfa-2, Polietilenglicoles, Ribavirina.
Resumen:	Depression is one of the main reasons for treatment withdrawal and failure in chronic hepatitis C patients treated with interferon. Antidepressants are useful for its treatment, but whether they can also be used for prevention has yet to be established.
Link:	./index.php?lvl=notice_display&id=27980

[artículo] Prophylactic treatment with escitalopram of pegylated interferon alfa 2a induced depression in hepatitis C. : a 12 week, randomized, double-blind, placebo controlled trial [texto impreso] / Crisanto Díez Quevedo, Autor ; Helena Masnou, Autor ; Ramon Planas, Autor . - 2022 . - pp. 522-528.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2011 - Vol.72 - No. 4 (Abril) . - pp. 522-528

Palabras clave:	Antivirales, Citalopram, Trastorno depresivo mayor, Hepatitis C., Interferón alfa-2, Polietilenglicoles, Ribavirina.
Resumen:	Depression is one of the main reasons for treatment withdrawal and failure in chronic hepatitis C patients treated with interferon. Antidepressants are useful for its treatment, but whether they can also be used for prevention has yet to be established.
Link:	./index.php?lvl=notice_display&id=27980